Literature DB >> 12079727

Motor cortical excitability in schizophrenia.

Alvaro Pascual-Leone1, Dara S Manoach, Robert Birnbaum, Donald C Goff.   

Abstract

BACKGROUND: Transcranial magnetic stimulation (TMS) provides a method to examine cortico-cortical motor excitability and hemispheric asymmetry in unmedicated and medicated schizophrenia patients.
METHODS: Fourteen right-handed schizophrenia patients (seven on conventional neuroleptics and seven medication-free) were compared with seven right-handed, age- and gender-matched normal control subjects. Motor threshold for induction of motor-evoked potentials (MEPs) and bihemispheric intracortical inhibition and facilitation were measured with single-pulse and paired-pulse TMS.
RESULTS: Medicated patients showed an approximately 5% higher motor thresholds in both hemispheres than unmedicated patients and control subjects. Normal control subjects had a nearly 10% higher threshold for the left than the right hemisphere, whereas the opposite was true for the patient groups (5-10% higher threshold on the right than the left). Medicated patients showed significantly decreased intracortical inhibition relative to unmedicated patients and control subjects. This difference was more pronounced for the right than for the left hemisphere.
CONCLUSIONS: Treatment with conventional neuroleptics is associated with increased motor threshold and decreased intracortical inhibition, whereas unmedicated patients did not differ from normal control subjects on these measures; however, schizophrenia may be characterized by a reversed pattern of interhemispheric corticospinal excitability.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12079727     DOI: 10.1016/s0006-3223(02)01317-3

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  26 in total

Review 1.  Transcranial magnetic stimulation: studying motor neurophysiology of psychiatric disorders.

Authors:  Fumiko Maeda; Alvaro Pascual-Leone
Journal:  Psychopharmacology (Berl)       Date:  2003-06-26       Impact factor: 4.530

Review 2.  [Cortical excitability in schizophrenia. Studies using transcranial magnetic stimulation].

Authors:  T Wobrock; D Kadovic; P Falkai
Journal:  Nervenarzt       Date:  2007-07       Impact factor: 1.214

Review 3.  GABA abnormalities in schizophrenia: a methodological review of in vivo studies.

Authors:  Stephan F Taylor; Ivy F Tso
Journal:  Schizophr Res       Date:  2014-10-25       Impact factor: 4.939

4.  Aberrant Middle Prefrontal-Motor Cortex Connectivity Mediates Motor Inhibitory Biomarker in Schizophrenia.

Authors:  Xiaoming Du; Fow-Sen Choa; Joshua Chiappelli; Krista M Wisner; George Wittenberg; Bhim Adhikari; Heather Bruce; Laura M Rowland; Peter Kochunov; L Elliot Hong
Journal:  Biol Psychiatry       Date:  2018-06-21       Impact factor: 13.382

5.  Treatment of auditory verbal hallucinations with transcranial magnetic stimulation in a patient with psychotic major depression: one-year follow-up.

Authors:  Catarina Freitas; Chester Pearlman; Alvaro Pascual-Leone
Journal:  Neurocase       Date:  2011-06-28       Impact factor: 0.881

6.  Abnormal gamma and beta MEG activity during finger movements in early-onset psychosis.

Authors:  Tony W Wilson; Erin Slason; Ryan Asherin; Eugene Kronberg; Peter D Teale; Martin L Reite; Donald C Rojas
Journal:  Dev Neuropsychol       Date:  2011       Impact factor: 2.253

7.  Test-retest reliability of short-interval intracortical inhibition and intracortical facilitation in patients with schizophrenia.

Authors:  Xiaoming Du; L Elliot Hong
Journal:  Psychiatry Res       Date:  2018-06-19       Impact factor: 3.222

8.  Aberrant high-frequency desynchronization of cerebellar cortices in early-onset psychosis.

Authors:  Tony W Wilson; Erin Slason; Olivia O Hernandez; Ryan Asherin; Martin L Reite; Peter D Teale; Donald C Rojas
Journal:  Psychiatry Res       Date:  2009-09-23       Impact factor: 3.222

9.  Increased cortical inhibition deficits in first-episode schizophrenia with comorbid cannabis abuse.

Authors:  Thomas Wobrock; Alkomiet Hasan; Berend Malchow; Claus Wolff-Menzler; Birgit Guse; Nicolas Lang; Thomas Schneider-Axmann; Ullrich K H Ecker; Peter Falkai
Journal:  Psychopharmacology (Berl)       Date:  2009-12-09       Impact factor: 4.530

10.  Modulation of human motor cortex excitability by quetiapine.

Authors:  Berthold Langguth; Peter Eichhammer; Claus Spranz; Michael Landgrebe; Ulrich Frick; Philipp Sand; Göran Hajak
Journal:  Psychopharmacology (Berl)       Date:  2007-11-23       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.